Clal Insurance Enterprises Holdings LTD has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $9.57 Billion distributed in 126 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Invesco Exchange Traded Fd Tr with a value of $1.07B, Vanguard Index Fds S&P 500 ETF with a value of $798M, Teva Pharmaceutical Industries LTD with a value of $526M, Spdr S&P 500 ETF Trust with a value of $478M, and Financial Sector Spdr with a value of $342M.

Examining the 13F form we can see an increase of $684M in the current position value, from $8.88B to 9.57B.

Clal Insurance Enterprises Holdings LTD is based out at Tel Aviv, L3

Below you can find more details about Clal Insurance Enterprises Holdings LTD portfolio as well as his latest detailed transactions.

Portfolio value $9.57 Billion
ETFs: $3.88 Billion
Technology: $2.77 Billion
Healthcare: $703 Million
Communication Services: $672 Million
Industrials: $357 Million
Consumer Cyclical: $269 Million
Utilities: $246 Million
Basic Materials: $207 Million
Other: $251 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 126
  • Current Value $9.57 Billion
  • Prior Value $8.88 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 13 stocks
  • Additional Purchases 25 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 46 stocks
Track This Portfolio

Track Clal Insurance Enterprises Holdings LTD Portfolio

Follow Clal Insurance Enterprises Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.